Mon, November 9, 2026
|
CannabisInsightKorea's Cannabis Business & Policy Media
R&D & TechUnited States2026-10-22

Pilot CBD Trial Signals Lower Opioid Use After Knee Surgery; Primary Test Nonsignificant


Pilot CBD Trial Signals Lower Opioid Use After Knee Surgery; Primary Test Nonsignificant

A triple-blind 36-person pilot compared placebo with 400 mg and 800 mg perioperative CBD. The 400 mg opioid reduction was nonsignificant in the primary comparison and significant only post hoc. The 800 mg arm lacked benefit and had more adverse-event burden, so efficacy is not established.

For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.

Source

sciencedirect.com

CannabisInsight selects and summarizes news from external sources. Copyright in the original articles remains with the respective publishers or institutions. Follow the source links for full reporting and context.

Original Link

https://www.sciencedirect.com/science/article/abs/pii/S1526590026002956

Read Original →
#R&D & Tech#United States#Cannabis#Hemp